Impact of Alcohol Misuse on Cognitive and Respiratory Outcomes in COVID-19-associated Acute Respiratory Failure
滥用酒精对 COVID-19 相关急性呼吸衰竭患者认知和呼吸结果的影响
基本信息
- 批准号:10491334
- 负责人:
- 金额:$ 27.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-22 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAcute Respiratory Distress SyndromeAcute respiratory failureAddressAdmission activityAdultAlcohol consumptionAlcoholsAutomobile DrivingBrainCOVID-19COVID-19 pandemicCOVID-19 patientCOVID-19 survivorsCOVID-19/ARDSCharacteristicsClinicCognitionCognitiveColoradoConsumptionConvalescenceCoronavirusCritical IllnessDataDeliriumDevelopmentDiagnosisEnrollmentFunctional disorderFundingGoalsHealthHealth systemHigh PrevalenceHospitalizationHospitalsHypoxemic Respiratory FailureImpaired cognitionImpairmentInfectionIntensive Care UnitsInterventionInvestigationLungMechanical VentilatorsMechanical ventilationMental HealthMonoclonal Antibody R24Morbidity - disease rateNational Institute on Alcohol Abuse and AlcoholismNeurocognitiveOutcomePatientsPost-Acute Sequelae of SARS-CoV-2 InfectionPredispositionRecording of previous eventsRecoveryReportingResearchResidual stateResourcesRespiration DisordersRespiratory FailureRespiratory physiologyRetrospective cohortRiskRisk FactorsRoleServicesSeveritiesSeverity of illnessSubgroupSurvivorsUniversitiesWaxesWorkalcohol misusealcohol researchbrain dysfunctioncohorthealth assessmentimprovedlung developmentlung injurymental statemortalitymultidisciplinarypandemic diseaseprospectivepulmonary functionrespiratoryrespiratory healthresponse
项目摘要
Project Summary/Abstract
During the Coronavirus (COVID)-19 pandemic, the number of patients diagnosed with the acute respiratory
distress syndrome (ARDS) has increased dramatically in the US. COVID-19-associated ARDS is characterized
by high morbidity, including a requirement for protracted mechanical ventilator support. In a substantial
percentage of patients who survive hospitalization, deficits including neurocognitive dysfunction and residual
pulmonary impairment have been reported as so-called Post-Acute Sequelae of COVID-19 (PASC). Therefore,
it is imperative to urgently establish addressable factors that drive poor outcomes. Prior to the COVID-19
pandemic, investigations by our research group demonstrated that alcohol misuse is associated with an
increased severity of ARDS, which may contribute to residual pulmonary dysfunction in survivors. Alcohol
misuse can also propagate development of delirium that may increase risk for cognitive impairment in
recovery. Notably, delirium has been reported in half of all COVID-19 patients in the ICU, and alcohol misuse
appears to increase odds for its development. Although reports of increasing alcohol misuse during the
pandemic are widespread and might be one modifiable factor driving severity of illness and outcomes, its
impact on the trajectory of illness in COVID-19 has not been fully evaluated. The goal of this proposal is to
determine if alcohol misuse promotes ICU delirium that in turn increases requirements for mechanical
ventilation among patients with COVID-19-associated ARDS. Also, we wish to establish if alcohol misuse
contributes to persistent cognitive and respiratory PASC in COVID-19 survivors. To address these questions,
two aims are proposed. Aim 1: In hospitalized patients with COVID-19-associated ARDS, determine if alcohol
misuse is associated with increased mechanical ventilation requirements, and if delirium further influences this
relationship. Investigations will be conducted in a prospectively enrolled cohort of patients with COVID-19-
associated ARDS, who are in the ICU at the University of Colorado Hospital (Aim 1a), and in a retrospective
cohort of hospitalized patients with COVID-19, previously admitted in the University of Colorado Health system
(Aim 1b). Aim 2: Among patients recovering from COVID-19, determine the impact of alcohol misuse on
cognition and respiratory function in recovery, accounting for characteristics of acute illness that include
requirements for mechanical ventilation and ICU delirium. Investigations will be conducted in patients followed
in a multidisciplinary COVID-19 Recovery Clinic, who will have cognitive, mental, and respiratory health
evaluated over the year following hospital discharge. Our proposed research will help determine if patients with
alcohol misuse warrant targeted strategies to identify and treat delirium in the setting of COVID-19-associated
respiratory failure, and it will clarify if hospitalized patients with COVID-19 and alcohol misuse represent a
unique subgroup at risk for PASC who may merit specific services or interventions.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELLEN L BURNHAM其他文献
ELLEN L BURNHAM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELLEN L BURNHAM', 18)}}的其他基金
Impact of Dual Alcohol and Cannabis Use on Lung
双重酒精和大麻使用对肺的影响
- 批准号:
10302164 - 财政年份:2021
- 资助金额:
$ 27.33万 - 项目类别:
Impact of Alcohol Misuse on Cognitive and Respiratory Outcomes in COVID-19-associated Acute Respiratory Failure
滥用酒精对 COVID-19 相关急性呼吸衰竭患者认知和呼吸结果的影响
- 批准号:
10391807 - 财政年份:2021
- 资助金额:
$ 27.33万 - 项目类别:
Impact of Dual Alcohol and Cannabis Use on Lung
双重酒精和大麻使用对肺的影响
- 批准号:
10471332 - 财政年份:2021
- 资助金额:
$ 27.33万 - 项目类别:
Impact of Alcohol Misuse on Cognitive and Respiratory Outcomes in COVID-19-associated Acute Respiratory Failure
滥用酒精对 COVID-19 相关急性呼吸衰竭患者认知和呼吸结果的影响
- 批准号:
10671588 - 财政年份:2021
- 资助金额:
$ 27.33万 - 项目类别:
Celiac disease signatures in Down syndrome (KL2 Admin Suppl)
唐氏综合症的乳糜泻特征(KL2 Admin Suppl)
- 批准号:
10117961 - 财政年份:2018
- 资助金额:
$ 27.33万 - 项目类别:
Clinical Resource for Lung and Alcohol Investigations
肺和酒精研究的临床资源
- 批准号:
8078579 - 财政年份:2011
- 资助金额:
$ 27.33万 - 项目类别:
CoPARC: Colorado Pulmonary Alcohol Research Collaborative
CoPARC:科罗拉多州肺酒精研究合作组织
- 批准号:
9926794 - 财政年份:2011
- 资助金额:
$ 27.33万 - 项目类别:
相似海外基金
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 27.33万 - 项目类别:
Research Grant
The Association Between Aging, Inflammation, and Clinical Outcomes in Acute Respiratory Distress Syndrome
衰老、炎症与急性呼吸窘迫综合征临床结果之间的关联
- 批准号:
10722669 - 财政年份:2023
- 资助金额:
$ 27.33万 - 项目类别:
Sedatives Pharmacology in Acute Respiratory Distress Syndrome- SPA
急性呼吸窘迫综合征中的镇静药理学 - SPA
- 批准号:
491387 - 财政年份:2023
- 资助金额:
$ 27.33万 - 项目类别:
Fellowship Programs
New mechanism-based TREM-1 therapy for acute respiratory distress syndrome
基于新机制的 TREM-1 疗法治疗急性呼吸窘迫综合征
- 批准号:
10678788 - 财政年份:2023
- 资助金额:
$ 27.33万 - 项目类别:
Great Lakes Clinical Center of the Acute Respiratory Distress Syndrome, Pneumonia and Sepsis (APS) Consortium
急性呼吸窘迫综合征、肺炎和败血症 (APS) 联盟五大湖临床中心
- 批准号:
10646578 - 财政年份:2023
- 资助金额:
$ 27.33万 - 项目类别:
Effect of ADAMTS13 on pathogenesis of acute respiratory distress syndrome
ADAMTS13 对急性呼吸窘迫综合征发病机制的影响
- 批准号:
23K08447 - 财政年份:2023
- 资助金额:
$ 27.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)
一种新型合成生物学衍生的微生物疗法,可治疗病毒引起的急性呼吸窘迫综合征(ARDS)
- 批准号:
10601865 - 财政年份:2023
- 资助金额:
$ 27.33万 - 项目类别:
Development of drug therapy targeting ferroptosis, iron-dependent cell death for acute respiratory distress syndrome.
开发针对铁死亡(急性呼吸窘迫综合征的铁依赖性细胞死亡)的药物疗法。
- 批准号:
23K08360 - 财政年份:2023
- 资助金额:
$ 27.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Sustainable Implementation of Prone Positioning for the Acute Respiratory Distress Syndrome
持续实施俯卧位治疗急性呼吸窘迫综合征
- 批准号:
10722194 - 财政年份:2023
- 资助金额:
$ 27.33万 - 项目类别:
Point-of-care system to assess the risk of trauma-induced acute respiratory distress syndrome
用于评估创伤引起的急性呼吸窘迫综合征风险的护理点系统
- 批准号:
10594793 - 财政年份:2023
- 资助金额:
$ 27.33万 - 项目类别:














{{item.name}}会员




